Meningococcal polysaccharide [serotypes A, C, W-135, Y] vaccine is under clinical development by CanSino Biologics and currently in Phase III for Neisseria meningitidis Infections. According to ...

VISION Network researchers report that across the board these ... New mRNA Vaccine Created to Prevent and Treat C. Difficile Oct. 17, 2024 — A new vaccine provides hope for treating and even ...

Vaccines protect babies and children from potentially life-threatening diseases. Widespread childhood vaccination has reduced or eliminated deadly diseases like polio and smallpox. Vaccines currently ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Influenza comes in four main subtypes—A, B, C, and D—and two, A and B, cause most infections in people. (H5N1 is type A.) Hensley developed a vaccine candidate that can recognize all 20 of the ...

Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

GARDASIL 9 can be given at the same time as GARDASIL 9 can be given at the same time as: Menactra [Meningococcal (Groups A, C, Y and W-135) Vaccine] Adacel [Tetanus, Diptheria and Acellular ...

Most people experience only mild side effects from the hep B vaccine. Common side effects include local pain at the injection site, headache, and fever. Very rarely, more serious adverse ...

Delivering the vaccine required ultra cold freezers (minus 80°C); none were available in the country. We had to address vaccine hesitancy among the population of Guinea, including the medical and ...

Can you get a vaccine to prevent all cancers? Reports in Russia’s state-run news agency claimed this week that Russian scientists have developed an mRNA vaccine that has shown the ability to suppress ...

Today it is driving efforts to create a new generation of therapies known as “cancer vaccines” that aim to train the immune system to recognise tumours and fight their spread. Trials are now ...